SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000950170-24-034178
Filing Date
2024-03-20
Accepted
2024-03-20 16:15:59
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-1 apvo-2024-s1_-_public.htm S-1 877704
2 EX-4.19 apvo-ex4_19.htm EX-4.19 159406
3 EX-4.20 apvo-ex4_20.htm EX-4.20 159603
4 EX-4.21 apvo-ex4_21.htm EX-4.21 318489
5 EX-4.22 apvo-ex4_22.htm EX-4.22 158809
6 EX-5.1 apvo-ex5_1.htm EX-5.1 31618
7 EX-23.1 apvo-ex23_1.htm EX-23.1 4548
8 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 103384
9 GRAPHIC img57496738_0.jpg GRAPHIC 7761
10 GRAPHIC img136687220_0.jpg GRAPHIC 6733
11 GRAPHIC img136687220_1.jpg GRAPHIC 59612
12 GRAPHIC img136687220_2.jpg GRAPHIC 528046
13 GRAPHIC img136687220_3.jpg GRAPHIC 4584
  Complete submission text file 0000950170-24-034178.txt   2650563
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-278103 | Film No.: 24767983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)